Michael Rice | Investor Relations, LifeSci Advisors |
Chaim Lebovits | President & Chief Executive Officer |
Alla Patlis | Interim Chief Financial Officer |
Stacy Lindborg | Executive Vice President & Chief Development Office |
Ralph Kern | President & Chief Medical Officer |
David Setboun | Executive Vice President & Chief Operating Officer |
Michael Rabinowitz | Maxim Group |
David Bautz | Zacks Small Cap Research |
Good day, ladies and gentlemen, and welcome to the BrainStorm Cell Therapeutics third quarter 2021 earnings call. At this time, all participants have been placed on listen-only mode, and the floor will be opened for questions and comments after the presentation. It is now my pleasure to turn the floor over to your host, Michael Rice of LifeSci Advisors. Sir, the floor is yours.
Good morning and thank you for joining us.